ENZ
Enzo Biochem, Inc.
Delisted
ENZ was delisted on the 17th of April, 2025.
49 hedge funds and large institutions have $45.6M invested in Enzo Biochem, Inc. in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 11 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
71% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 7
76% less call options, than puts
Call options by funds: $179K | Put options by funds: $740K
Holders
49
Holding in Top 10
3
Calls
$179K
Puts
$740K
Top Buyers
| 1 | +$115K | |
| 2 | +$35K | |
| 3 | +$32.9K | |
| 4 |
Fuller & Thaler Asset Management
San Mateo,
California
|
+$30.2K |
| 5 |
Bank of New York Mellon
New York
|
+$4.44K |
Top Sellers
| 1 | -$451K | |
| 2 | -$238K | |
| 3 | -$206K | |
| 4 |
BlackRock
New York
|
-$139K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$123K |